UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use

European heart journal, 2009-08, Vol.30 (16), p.1964-1977

Wallentin, Lars

2009

Volltextzugriff (PDF)

The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)

Heart, 2010-10, Vol.96 (20), p.1617-1621

2010

Volltextzugriff (PDF)

Biomarkers in atrial fibrillation: a clinical review

European heart journal, 2013-05, Vol.34 (20), p.1475-1480

2013

Volltextzugriff (PDF)

Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK

The Lancet (British edition), 2014-04, Vol.383 (9925), p.1305-1312

2014

Volltextzugriff (PDF)

Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry

European heart journal, 2016-11, Vol.37 (44), p.3335-3342

2016

Volltextzugriff (PDF)

New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis

European heart journal, 2013-06, Vol.34 (22), p.1670-1680

2013

Volltextzugriff (PDF)

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial

Journal of thrombosis and haemostasis, 2011-11, Vol.9 (11), p.2168-2175

2011

Volltextzugriff (PDF)

Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register

Journal of internal medicine, 2010-07, Vol.268 (1), p.40-49

2010

Volltextzugriff (PDF)

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

European heart journal, 2015-05, Vol.36 (20), p.1264-1272

2015

Volltextzugriff (PDF)

Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome

Journal of internal medicine, 2021-08, Vol.290 (2), p.392-403

2021

Volltextzugriff (PDF)

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

European heart journal, 2009-10, Vol.30 (19), p.2346-2353

2009

Volltextzugriff (PDF)

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

Journal of internal medicine, 2018-01, Vol.283 (1), p.83-92

2018

Volltextzugriff (PDF)

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

European heart journal, 2006-04, Vol.27 (7), p.789-795

2006

Volltextzugriff (PDF)

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

European heart journal, 2006-05, Vol.27 (10), p.1166-1173

2006

Volltextzugriff (PDF)

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

JAMA : the journal of the American Medical Association, 2001-11, Vol.286 (17), p.2107

2001

Volltextzugriff (PDF)

D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial

Journal of thrombosis and haemostasis, 2014-09, Vol.12 (9), p.1401-1412

2014

Volltextzugriff (PDF)

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE‐LY trial

Journal of internal medicine, 2018-03, Vol.283 (3), p.282-292

2018

Volltextzugriff (PDF)

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.699-707

2015

Volltextzugriff (PDF)

Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission

Heart (British Cardiac Society), 2007-12, Vol.93 (12), p.1577-1583

2007

Volltextzugriff (PDF)

Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction

European heart journal, 2007-12, Vol.28 (23), p.2858-2865

2007

Volltextzugriff (PDF)

Bivalirudin versus Heparin in non-ST and ST-segment elevation myocardial infarction - a registry-based randomized clinical trial (RRCT) in the SWEDEHEART registry (the VALIDATE-SWEDEHEART-trial)

The American heart journal, 2016-05, Vol.175, p.36-46

2016

Volltextzugriff (PDF)

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology

European heart journal, 2000-09, Vol.21 (17), p.1406-1432

2000

Volltextzugriff (PDF)

The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)

European heart journal. Quality of care & clinical outcomes, 2021-11, Vol.7 (5), p.431-437

2021

Volltextzugriff (PDF)

Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial

Journal of internal medicine, 2020-08, Vol.288 (2), p.248-259

2020

Volltextzugriff (PDF)

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation

Heart (British Cardiac Society), 2008-07, Vol.94 (7), p.867-873

2008

Volltextzugriff (PDF)

1 – 25 von 785

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(742)
Mit Volltextzugriff
(686)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(457)
Humans
(453)
Life Sciences & Biomedicine
(427)
Male
(311)
Cardiovascular System & Cardiology
(301)
Female
(290)
Cardiac & Cardiovascular Systems
(272)
Middle Aged
(267)
Aged
(253)
Biological And Medical Sciences
(241)
Medical Sciences
(236)
Cardiology. Vascular System
(164)
Heart
(152)
Coronary Heart Disease
(136)
Medicine
(136)
Medicin
(132)
Medicin Och Hälsovetenskap
(122)
Adult
(114)
Heart Attacks
(108)
Treatment Outcome
(105)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Heart Journal
(165)
Journal Of The American College Of Cardiology
(51)
The American Heart Journal
(39)
Circulation
(37)
The Lancet
(30)
Läkartidningen
(29)
Heart
(26)
The American Journal Of Cardiology
(17)
The New England Journal Of Medicine
(14)
Thrombosis And Haemostasis
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(7)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use

The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)

Biomarkers in atrial fibrillation: a clinical review

Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK

Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry

New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial

Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

Excessive daytime sleepiness, morning tiredness and major adverse cardiovascular events in patients with chronic coronary syndrome

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE‐LY trial

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial

Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission

Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction

Bivalirudin versus Heparin in non-ST and ST-segment elevation myocardial infarction - a registry-based randomized clinical trial (RRCT) in the SWEDEHEART registry (the VALIDATE-SWEDEHEART-trial)

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology

The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)

Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation

Suchergebnisse filtern